This is a community-generated profile. If you would like to claim it, please .
DiscoverStartupsEuclises PharmaceuticalsEuclises Pharmaceuticals Funding Rounds, Valuation & Investors
Euclises Pharmaceuticals Funding
$0
44 rounds
Euclises Pharmaceuticals is active in the following markets / industries: biotechnology. The company has secured funding across 4 rounds and is valued at $0. Their most recent funding was raised on April 8, 2015.
Funding Rounds
A
$700000Series AApr 2015
A
$1300000U
$300000U
$175000UnknownMay 2012
Investors of Euclises Pharmaceuticals
Chris began his career on Wall Street in 1989 on the Institutional Block Trading Desk at Shearson Lehman Hutton in New York City.
Ryan Rakestraw is an Associate Director at Temasek focused on early-stage investments in Food and Agriculture
ABC Laboratories
Missouri Technology Corporation
The MTC profile page has moved here: (https://angel.co/missouri-technology-corporation).
Helix Fund
CEO of iSelectFund. 20yrs of Startup, Operations, Venture and R&D experience. Successful exits in energy, pharma and aerospace.
St. Louis Arch Angels
Rounds
A
A
U
Missouri Technology
Rounds
A